F S&P 500
5,248.50 +2.25 (+0.04%) F Dow Jones
39,631.00 -11.00 (-0.03%) F Nasdaq
18,277.50 +22.50 (+0.12%) E-mini Russell 2000 Index Futur
2,069.70 +1.80 (+0.09%) Petróleo
78.06 -0.20 (-0.26%) Oro
2,361.90 -13.10 (-0.55%)
Inspira Technologies Oxy B.H.N. Ltd. (IINN)
Fuera de horario:
Inspira Technologies Oxy B.H.N. Ltd.
2 Ha-Tidhar Street
Ra'anana 4366504
Israel
972 4 6230333
https://inspira-technologies.com
Sector(es): Healthcare
Industria: Medical Devices
Empleados a tiempo completo: 37
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Dagi Shahar Ben-Noon | Co-Founder, CEO & Director | 290.31k | N/D | 1976 |
| Mr. Joe Hayon | Co-Founder, President & Director | 292.85k | N/D | 1974 |
| Ms. Yafit Tehila | Chief Financial Officer | 217.12k | N/D | 1983 |
| Mr. Avi Shabtai | COO and VP of Research & Development | 339.36k | N/D | 1974 |
| Ms. Daniella Yeheskely-Hayon Ph.D. | Chief Technology Officer | 217.13k | N/D | 1977 |
| Meshira Greenberg | Administrative Manager | N/D | N/D | N/D |
| Adi Shmueli | Marketing & Communications Manager | N/D | N/D | N/D |
Descripción
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure. Its lead product is the INSPIRA augmented respiration technology (Gen 2) device, a life support designed to provide Adaptive Blood Oxygenation that to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Gestión corporativa
La calificación ISS Governance QuickScore de Inspira Technologies Oxy B.H.N. Ltd. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
